Ecovyst Inc.
ECVT NYSE Chemicals & Allied Products Financials FY2016βFY2025
What Ecovyst Inc. does
No business description yet.
- Legal name
- Ecovyst Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001708035-26-000053
0001708035
Revenue and margins
Ecovyst Inc. had $724M of revenue in fiscal 2025, up 20.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $69.9M in fiscal 2025, 9.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Ecovyst Inc. returned $46.9M to shareholders in fiscal 2025, 67% of free cash flow. The diluted share count fell 1.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Ecovyst Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $141M | $111M | $88.4M | $131M | $197M |
| Debt incl. finance leases | $897M | $885M | $876M | $866M | $393M |
| Net debt / EBITDA | 5.6x | 4.2x | 4.5x | 4.2x | 1.5x |
| Debt / equity | 1.2x | 1.2x | 1.2x | 1.2x | 0.7x |
| Interest coverage | 1.5x | 2.8x | 2.0x | 2.3x | 1.9x |
| Current ratio | 2.0x | 2.1x | 2.1x | 2.6x | 2.6x |
| Quick ratio | 1.6x | 1.7x | 1.7x | 2.5x | 2.4x |
| Total assets | $1.9B | $1.9B | $1.8B | $1.8B | $1.3B |
| Total liabilities | $1.2B | $1.2B | $1.1B | $1.1B | $658M |
| Shareholders' equity | $741M | $707M | $705M | $700M | $603M |
| Net debt (β = net cash) | $756M | $774M | $788M | $734M | $195M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 7 / 9 | 6 / 9 | 6 / 9 | 4 / 9 | 4 / 9 | 7 / 9 | 5 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | β4.8% | β2.5% | β4.4% | β4.4% | β13.4% | β10.5% | β5.9% | β3.6% | β8.6% | β13.8% |
| Altman Z'' | 0.78 | 1.23 | 1.37 | 1.37 | 1.09 | 0.81 | 1.07 | 1.13 | 1.35 | 1.70 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.1B | $1.5B | $1.2B | $533M | $496M | $611M | $820M | $585M | $598M | $724M |
| Gross profit | $254M | $377M | $303M | $167M | $151M | $177M | $225M | $166M | $163M | $158M |
| Research and development | $7.3M | $13.9M | $13.7M | $7.4M | $7.1M | $7.5M | $7.2M | $7.8M | $6.8M | β |
| Operating income | $81.5M | $166M | $156M | $66.0M | $51.6M | $54.6M | $104M | $89.6M | $85.1M | $64.9M |
| Interest expense | $140M | $179M | $90.8M | $66.9M | $50.4M | $37.0M | $37.2M | $44.7M | $36.5M | $34.2M |
| Pretax income | β$69.1M | β$60.6M | $84.0M | $43.4M | $2.2M | $13.9M | $94.7M | $56.9M | $45.2M | $25.8M |
| Income tax | $10.0M | β$119M | $33.6M | $12.3M | β$52.1M | $12.1M | $24.9M | $8.7M | β$0.3M | $19.5M |
| Net income | β$79.7M | $57.6M | $58.3M | $79.5M | β$279M | β$140M | $73.7M | $71.2M | β$6.7M | β$71.1M |
| Diluted EPS | β$1.02 | $0.52 | $0.43 | $0.59 | β$2.04 | β$1.02 | $0.55 | $0.60 | β$0.06 | β$0.61 |
| Diluted shares | 0.08B | 0.11B | 0.13B | 0.14B | 0.14B | 0.14B | 0.14B | 0.12B | 0.12B | 0.12B |
| Cash flow | ||||||||||
| Cash from operations | $123M | $165M | $249M | $268M | $224M | $130M | $187M | $138M | $150M | $140M |
| Capital expenditure | $121M | $140M | $112M | $55.3M | $54.8M | $60.0M | $58.9M | $59.0M | $55.6M | $70.4M |
| Free cash flow | $1.3M | $24.7M | $137M | $213M | $169M | $69.9M | $128M | $78.6M | $94.3M | $69.9M |
| Depreciation and amortization | $128M | $177M | $154M | $74.8M | $76.9M | $79.7M | $79.2M | $84.6M | $89.4M | $67.8M |
| Stock-based compensation | $5.4M | $8.8M | $18.4M | $13.3M | $17.2M | $31.8M | $20.6M | $13.0M | $11.1M | $9.7M |
| Acquisitions | $1.8B | $41.6M | $1.0M | $0.0M | $0.0M | $42.6M | $0.5M | $0.0M | $0.0M | $41.5M |
| Share buybacks | β | β | β | β | β | $0.0M | $137M | $78.7M | $5.0M | $46.9M |
| Dividends paid | β | β | $0.0M | $0.0M | $244M | $436M | $0.0M | $0.0M | β | β |
| Dividends and buybacks | β | β | $0.0M | $0.0M | $244M | $436M | $137M | $78.7M | $5.0M | $46.9M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $70.7M | $66.2M | $37.2M | $36.1M | $113M | $141M | $111M | $88.4M | $131M | $197M |
| Total debt | $2.6B | $2.2B | $2.1B | $1.8B | $1.4B | $882M | $875M | $868M | $861M | $393M |
| Finance lease liabilities | β | β | β | $0.5M | $0.6M | $14.8M | $10.3M | $7.9M | $4.9M | β |
| Current assets | $493M | $549M | $559M | $569M | $429M | $292M | $268M | $246M | $304M | $319M |
| Current liabilities | $242M | $288M | $256M | $270M | $202M | $145M | $129M | $119M | $115M | $121M |
| Inventory | $227M | $262M | $265M | $138M | $52.8M | $53.8M | $44.4M | $45.1M | $18.0M | $26.8M |
| Property and equipment, net | $1.2B | $1.2B | $1.2B | $1.0B | $592M | $596M | $585M | $577M | $459M | $481M |
| Goodwill | $1.2B | $1.3B | $970M | $391M | $392M | $406M | $403M | $404M | $327M | $327M |
| Intangible assets | $817M | $786M | $728M | $555M | $137M | $146M | $130M | $117M | $67.7M | $59.3M |
| Total assets | $4.3B | $4.4B | $4.3B | $4.3B | $3.2B | $1.9B | $1.9B | $1.8B | $1.8B | $1.3B |
| Total liabilities | $3.2B | $2.8B | $2.7B | $2.5B | $1.9B | $1.2B | $1.2B | $1.1B | $1.1B | $658M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $1.0B | $1.6B | $1.7B | $1.8B | $1.3B | $741M | $707M | $705M | $700M | $603M |
| Margins | ||||||||||
| Gross margin | 23.9% | 25.6% | 24.7% | 31.4% | 30.4% | 28.9% | 27.4% | 28.5% | 27.3% | 21.8% |
| Operating margin | 7.7% | 11.3% | 12.7% | 12.4% | 10.4% | 8.9% | 12.7% | 15.3% | 14.2% | 9.0% |
| EBITDA margin | 19.7% | 23.3% | 25.2% | 26.4% | 25.9% | 22.0% | 22.4% | 29.8% | 29.2% | 18.3% |
| Net margin | β7.5% | 3.9% | 4.7% | 14.9% | β56.2% | β22.9% | 9.0% | 12.2% | β1.1% | β9.8% |
| FCF margin | 0.1% | 1.7% | 11.1% | 39.9% | 34.0% | 11.4% | 15.6% | 13.4% | 15.8% | 9.7% |
| Returns | ||||||||||
| Return on capital | 1.8% | 3.5% | 2.7% | 1.3% | 2.0% | 2.4% | 5.2% | 5.1% | 6.0% | 5.3% |
| Return on capital employed | 2.0% | 4.0% | 3.8% | 1.6% | 1.7% | 3.1% | 5.9% | 5.2% | 5.0% | 5.7% |
| Return on equity | β7.8% | 4.3% | 3.5% | 4.6% | β18.2% | β13.9% | 10.2% | 10.1% | β0.9% | β10.9% |
| Return on assets | β1.9% | 1.3% | 1.3% | 1.8% | β7.4% | β5.5% | 3.9% | 3.8% | β0.4% | β4.6% |
| Return on tangible equity | β | β | β | 9.5% | β37.3% | β74.1% | 42.3% | 38.6% | β2.2% | β32.7% |
| Growth | ||||||||||
| Revenue growth | β | 38.3% | β16.5% | β56.6% | β6.9% | 23.2% | 34.2% | β28.7% | 2.3% | 20.9% |
| Net income growth | β | β | 1.2% | 36.4% | β450.5% | β | β | β3.5% | β109.3% | β |
| EPS growth | β | β | β17.3% | 37.2% | β445.8% | β | β | 9.1% | β110.0% | β |
| FCF growth | β | 1,818.5% | 454.2% | 55.3% | β20.6% | β58.6% | 82.8% | β38.5% | 20.0% | β25.9% |
| Share count change | β | 43.1% | 20.6% | 0.6% | 0.7% | 0.9% | β1.9% | β11.5% | β1.7% | β1.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 11.9x | 6.3x | 6.7x | 12.8x | 10.0x | 5.6x | 4.2x | 4.5x | 4.2x | 1.5x |
| Debt / equity | 2.5x | 1.4x | 1.3x | 1.0x | 1.1x | 1.2x | 1.2x | 1.2x | 1.2x | 0.7x |
| Interest coverage | 0.6x | 0.9x | 1.7x | 1.0x | 1.0x | 1.5x | 2.8x | 2.0x | 2.3x | 1.9x |
| Current ratio | 2.0x | 1.9x | 2.2x | 2.1x | 2.1x | 2.0x | 2.1x | 2.1x | 2.6x | 2.6x |
| Quick ratio | 1.1x | 1.0x | 1.1x | 1.6x | 1.9x | 1.6x | 1.7x | 1.7x | 2.5x | 2.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 11.4% | 9.5% | 9.1% | 10.4% | 11.1% | 9.8% | 7.2% | 10.1% | 9.3% | 9.7% |
| Stock comp / revenue | 0.5% | 0.6% | 1.5% | 2.5% | 3.5% | 5.2% | 2.5% | 2.2% | 1.9% | 1.3% |
| Payouts / FCF | β | β | 0.0% | 0.0% | 144.4% | 623.4% | 107.0% | 100.2% | 5.3% | 67.2% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 7.0 | 6.0 | 6.0 | 4.0 | 4.0 | 7.0 | 5.0 | 5.0 | 6.0 |
| Altman Z'' | 0.8 | 1.2 | 1.4 | 1.4 | 1.1 | 0.8 | 1.1 | 1.1 | 1.4 | 1.7 |
| Accruals ratio | β4.8% | β2.5% | β4.4% | β4.4% | β13.4% | β10.5% | β5.9% | β3.6% | β8.6% | β13.8% |
Source: SEC EDGAR XBRL filings (CIK 0001708035). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.